Trial Profile
Phase 2b trial of delpazolid.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2018
Price :
$35
*
At a glance
- Drugs Delpazolid (Primary)
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- 01 Aug 2018 New trial record
- 24 Jul 2018 According to HaiHe Biopharma media release, company has filled IND in US in January, 2018